SCIRX
Price
$221.35
Change
+$1.07 (+0.49%)
Updated
Jun 22 closing price
Net Assets
30.05B
WFSTX
Price
$11.37
Change
+$0.10 (+0.89%)
Updated
Jun 22 closing price
Net Assets
376.77M
Interact to see
Advertisement

SCIRX vs WFSTX

SCIRX vs WFSTX Comparison Chart in %
View a ticker or compare two or three
VS
SCIRX vs. WFSTX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCIRX is a Buy and WFSTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCIRX has more cash in the bank: 30.1B vs. WFSTX (377M). SCIRX (0.00) and WFSTX (0.00) have matching dividends . SCIRX was incepted earlier than WFSTX: SCIRX (23 years) vs WFSTX (26 years). SCIRX (1.41) is less costly to investors than WFSTX (1.30). WFSTX is a more actively managed with annual turnover of: 35.00 vs. SCIRX (33.00). SCIRX has a lower initial minimum investment than WFSTX: SCIRX (0) vs WFSTX (1000). SCIRX annual gain was more profitable for investors over the last year : 101.30 vs. WFSTX (-6.24). SCIRX return over 5 years is better than : 89.62 vs. WFSTX (-43.51).
SCIRXWFSTXSCIRX / WFSTX
Total Expense Ratio1.411.22116%
Annual Report Gross Expense Ratio1.411.30108%
Fund Existence23 years26 years-
Gain YTD59.03510.599557%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets30.1B377M7,984%
Annual Yield % from dividends0.000.00-
Returns for 1 year101.30-6.24-1,623%
Returns for 3 years135.5418.63727%
Returns for 5 years89.62-43.51-206%
Returns for 10 years330.3223.171,426%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR65.704.72
+7.74%
Nektar Therapeutics
SGMT7.100.42
+6.29%
Sagimet Biosciences
CCNEP24.75N/A
N/A
CNB Financial Corp
NYT72.08-0.98
-1.34%
New York Times Co
LNSR5.64-0.11
-1.83%
LENSAR